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Hsp31, the Escherichia coli hcha gene product, is a
molecular chaperone whose activity is inhibited by ATP
at high temperature. Its crystal structure reveals a pu-
tative Cys184, His185, and Asp213 catalytic triad similar to
that of the Pyrococcus horikoshii protease PH1704, sug-
gesting that it should display a proteolytic activity. A
preliminary report has shown that Hsp31 has an exceed-
ingly weak proteolytic activity toward bovine serum al-
bumin and a peptidase activity toward two peptide sub-
strates with small amino acids at their N terminus
(alanine or glycine), but the physiological significance
of this observation remains unclear. In this study, we
report that Hsp31 does not diplay any significant pro-
teolytic activity but has peptidolytic activity. The amin-
opeptidase cleavage preference of Hsp31 is Ala > Lys >
Arg > His, suggesting that Hsp31 is an aminopeptidase
of broad specificity. Its aminopeptidase activity is inhib-
ited by the thiol reagent iodoacetamide and is com-
pletely abolished in a C185A mutant, which is consistent
with Hsp31 being a cysteine peptidase. The aminopepti-
dase activity of Hsp31 is also inhibited by EDTA and
1,10-phenanthroline, in concordance with the impor-
tance of the putative His85, His122, and Glu90 metal-bind-
ing site revealed by crystallographic studies. An Hsp31-
deficient mutant accumulates more 8–12-mer peptides
than its parental strain, and purified Hsp31 can trans-
form these peptides into smaller peptides, suggesting
that Hsp31 has an important peptidase function both in
vivo and in vitro. Proteins interacting with Hsp31 have
been identified by reverse purification of a crude E. coli
extract on an Hsp31-affinity column, followed by SDS-
polyacrylamide electrophoresis and mass spectrometry.
The ClpA component of the ClpAP protease, the chaper-
one GroEL, elongation factor EF-Tu, and tryptophanase
were all found to interact with Hsp31, thus substantiat-
ing the role of Hsp31 as both chaperone and peptidase.
Every organism responds to a sudden increase in the envi-
ronmental temperature by the overexpression of a set of highly
conserved heat shock proteins (1, 2). Most of these heat shock
proteins function either as molecular chaperones, assisting in
protein folding and renaturation or as proteases which degrade
proteins that are beyond rescue.
Hsp31,1 the hchA gene product (formerly known as YedU), is
a heat-inducible homodimeric protein of 31-kDa subunits,
which was recently shown to exhibit molecular chaperone ac-
tivity (3, 4). It promotes the functional folding of citrate syn-
thase, -glucosidase, and alcohol dehydrogenase. It also pre-
vents the aggregation at 43 °C of citrate synthase and alcohol
dehydrogenase and interacts specifically with unfolded pro-
teins (3, 4). Although Hsp31 does not exhibit any ATPase
activity, some of its chaperone activities are partially inhibited
by ATP (3, 4). The crystal structure of Hsp31 was solved at 1.6
Å resolution and revealed a system of hydrophobic patches,
canyons, and grooves, which may stabilize partially unfolded
protein substrates and explain its chaperone activity (5). A
putative Cys-His-Asp catalytic triad that is only accessible
through a small pocket with a length of 14 Å, and an entrance
of about 4 Å was also revealed, suggesting that Hsp31 might
present a protease or more probably a peptidase activity (5–8).
Although initial attempts to determine whether Hsp31 func-
tions as a protease or peptidase were unsuccessful (3, 4), it was
recently reported that Hsp31 displays very weak protease ac-
tivity and a peptidase activity against Ala and Gly conjugated
to a fluorogenic group, but the physiological relevance of this
observation remains unclear (7). In the present study, we show
that Hsp31 is a broad specificity aminopeptidase with a pref-
erence for alanine and basic amino acids and that it is inhibited
by cysteine protease inhibitors and by the metal ion complexing
agents EDTA and 1,10-phenantroline. Furthermore, we show
that an Hsp31-deficient mutant accumulates increased
amounts of 8–12-mer peptides, which can be processed in vitro
to smaller peptides by purified Hsp31. Finally, we report that
Hsp31 specifically interacts with ClpA, GroEL, EF-Tu, and
tryptophanase. Our results suggest that, besides its chaperone
activity, Hsp31 plays an active role in the downstream proc-
essing of peptides generated by the ATP-dependent proteases.
EXPERIMENTAL PROCEDURES
Hsp31 Expression and Purification—The Escherichia coli B/r strain
AD494 (ara leu7967 lacX74 phoA phoR-malF3 F[lac (lacIq) pro]
trxB::kan [DE3] pLysS was purchased from Novagen. It was trans-
formed with plasmid pINTYEDU, which encodes the complete Hsp31/
YedU protein fused to a chitin-binding domain tag at its N terminus (3).
Cells were grown in LB broth in the presence of ampicillin and lysed by
sonication (3). The recombinant Hsp31 protein fused to the chitin-
binding domain was purified by affinity chromatography on a chitin
affinity column (intein-mediated purification with an affinity chitin-
binding tag kit from New England Biolabs, Inc.) as described previously
(3). The eluted Hsp31 protein was pure as judged by SDS-polyacryl-
amide gel electrophoresis. It was stored at20 °C in buffer (20 mM Tris,
pH 7.4, 50 mM KCl, 0.5 mM dithiothreitol) supplemented with 30%
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glycerol. The C185A mutant was constructed and purified as described
previously (7).
Construction of the Hsp31-deficient Strain—The one-step inactiva-
tion of the hcha gene encoding Hsp31 was done using the phage 
recombination (Red) system (9). The strategy is analogous to the PCR-
based gene deletion method in yeast, except E. coli cells carrying an
easily curable, low copy number plasmid (pSC101 (replication temper-
ature-sensitive derivative)-based plasmid pKD46 carrying the  Red
recombinase genes (9)) expressing the Red system was used. The basic
strategy is to replace a chromosomal sequence with a selectable anti-
biotic resistance gene that is generated by PCR by using primers with
50-nucleotide extensions homologous to the adjacent upstream or down-
stream flanking regions of the target gene and 20-nucleotide 3-end for
the amplification of kanamycin (kan) resistance gene. Replacement is
accomplished by Red-mediated recombination in these flanking ho-
mologies (9). Strain BW25113 (lacIq rrnB3 lacZ4787 hsdR514 (ar-
aBAD)567 (rhaBAD)568 rph-1) was used as the parent for construc-
tion of the hcha deletion mutant JW1950. Insertion of the kan
resistance cassette in the hcha gene is not likely to have a polar effect
on the expression of other genes, since the genes downstream of hcha
(yedV, coding for a putative sensor-like histidine kinase and YedW,
coding for a probable transcriptional regulatory protein) are transcribed
in the opposite direction (genolist.pasteur.fr/Colibri/). The construction
of the hcha deletion mutant is part of the systematic construction of
E. coli single gene deletion mutants.2
Protease and Peptidase Assays—Autolysis of Hsp31 in test tubes was
performed as described previously (3), and proteolysis products were
analyzed by SDS-PAGE. Gelatin-PAGE and casein-PAGE in-gel prote-
olysis assays were performed as described in (3, 12); 2 g of Hsp31 were
electrophoresed onto 12% SDS-polyacrylamide gels containing either
0.2% co-polymerized gelatin or 0.2% copolymerized casein, and proteo-
lytic activity was visualized by clearing zones resulting from gelatin or
casein hydrolysis (12). Gelatin and casein zymography was also per-
formed using electrophoresis under native conditions as described by
Fukiage et al.(13). Proteolysis of citrate synthase, -casein, and -ca-
sein was assayed by incubation of the reaction mixtures containing 2 g
of the protein substrate and 0.5 g of Hsp31 at 37 °C in 20 mM Tris, pH
8, 5 mM MgCl2. After incubation for appropriate periods, the reaction
was stopped with 2% SDS, and the samples were subjected to SDS-
PAGE. Proteolysis of insulin and insulin -chain were measured by
chromatographic analysis of proteolysis product on a C18 reverse phase
HPLC column (Vydac C18 250  4.6 mm, Hewlett-Packard) equili-
brated in 0.1% trifluoroacetic acid in water and eluted with a linear
gradient of 0–100% acetonitrile containing 0.1% trifluoroacetic acid.
Endopeptidase and aminopeptidase activities were assayed by
monitoring the production of 7-aminomethylcoumarin (amc) from the
fluorogenic amino acid or peptides substrates, succinyl-LLVY-amc,
t-butyloxycarbonyl-LAR-amc, Ac-YVAD-amc, AAF-amc, ALK-amc,
Ac-A-amc, L-Ala-amc, L-Arg-amc, L-Asp-amc, L-Asn-amc, L-Gly-
amc, L-Leu-amc, L-Lys-amc, L-Met-amc, L-Phe-amc, L-Pro-amc, L-Thr-
amc, L-Tyr-amc, L-Val-amc, L-Ser-amc, L-Cys-amc, L-His-amc,
L-Glu-amc as described previously (3, 10). One g of Hsp31 was
incubated at 37 °C for appropriate times (1–20 h, in conditions in
which the appearance of product is linear as a function of time) with
500 M substrate in 50 mM Tris, pH 8, 5 mM MgCl2, 1 mM dithiothre-
itol, 1% dimethyl sulfoxide, in a total volume of 100 l, and amc
fluorescence (excitation at 380 nm, emission at 460 nm) was meas-
ured after arrest of the reaction with 900 l 1% SDS. Carboxypepti-
dase activity was assayed by measuring the hydrolysis of hippuryl-
Phe or hippuryl-Arg as described previously (3, 11) The hydrolysis of
succinyl-AAA-p-nitroanilide was detected at 410 nm. The concentra-
tion of pure Hsp31 was determined from its A280/1 mg/ml  1.048
(Swiss-Prot, www.expasy.org/sprot/).
Isolation of Accumulated Peptides from Wild-type BW25113 and
Hsp31-deficient JW1950 Strains—Overnight cultures were diluted to
A600  0.05 and grown (exponential phase of growth) for 2.5 h to A600 
0.2 in minimal glucose medium (50 ml) containing 3 Ci of [3H]leucine/
ml (Amersham Pharmacia Biotech). The cultures were harvested by
centrifugation, washed twice with 0.85% NaCl, and resuspended in 1.5
ml 1 M acetic acid for extraction of peptides (14). The acetic acid
suspension was incubated for 20 min at 22 °C, and the insoluble frac-
tion was removed by centrifugation (20 min, 15,000  g).
Gel Filtration of Peptides—For HPLC gel filtration, 100 l of the
peptide solution was chromatographed on a TSK 2000 SW gel filtration
HPLC column (Hewlett-Packard) equilibrated with 1 mM acetic acid
and eluted with the same solvent at a flow rate of 0.5 ml/min. 0.5-ml
fractions were collected. Peptides were detected by radioactivity and
absorbance at 215 nm. For Bio-Gel P-2 gel filtration, the low molecular
weight peptides from the TSK 2000 HPLC column were concentrated by
lyophilization, resuspended in 50 mM Tris, pH 8, 5 mM MgCl2, and
incubated in the absence or in the presence of 2 g Hsp31, and 100 l
was loaded onto a 2-ml column (10 cm/0.3 cm) equilibrated in 100 mM
acetic acid. Dextran blue (molecular weight, 2,000,000), dextran yellow
(molecular weight, 20,000), (insulin B, molecular weight, 2000), vitamin
B12 (molecular weight, 1350), and leucine (molecular weight, 131) were
used as molecular weight standards.
Reverse Phase HPLC of Peptides—The low molecular weight peptides
from the TSK 2000 SW HPLC column were concentrated by lyophiliza-
tion and resuspended in 0.1% trifluoroacetic acid in water. 100 l was
analyzed by reverse phase HPLC (Vydac C18 250  4.6 mm, Hewlett-
Packard). The column was equilibrated in 0.1% trifluoroacetic acid in
water and eluted with a linear gradient of 0–100% acetonitrile contain-
ing 0.1% trifluoroacetic acid in 20 min at a flow rate of 0.3 ml/min and
the gradient started 10 min after injection. Peptides were detected by
radioactivity, by absorbance at 215 nm, and by fluorescamine reactivity
before or after prior alkaline hydrolysis as described in (14).
Detection of Hsp31 Partners by Reverse Purification—The recombi-
nant Hsp31 protein fused to a chitin-binding domain was loaded onto a
chitin affinity column and purified as described above, without the
dithiothreitol-induced elution step (2). An E. coli crude extract was
loaded onto this Hsp31 affinity column. The column was extensively
washed with 0.5 M NaCl, and proteins specifically bound were eluted
with 1% SDS. The eluted proteins were then separated by SDS-PAGE,
and the individual bands that were not retained by two control columns
were analyzed by MALDI-TOF mass spectrometry. One of these two
control columns was made with the chitin-binding domain alone, and
the other with the chitin-binding domain fused to YhbO, an E. coli
peptidase of 20 kDa under study in our laboratory.
Materials—Citrate synthase (from porcine heart), -casein, -casein,
insulin, insulin -chain, and all other chemicals were from Sigma and
were reagent grade. The molecular weight marker kit for gel filtration
chromatography was from Sigma. The fluorogenic peptides were from
either Bachem or Sigma.
RESULTS
Absence of Proteolytic Activity of Hsp31—As reported previ-
ously (3), we could not detect any proteolytic activity of Hsp31
toward gelatin or casein when using a polyacrylamide in-gel
assay similar to that used for the detection of PFP1 protease
activity (12), in which the substrate was incorporated uni-
formly in the gel (these negative results were obtained with
both SDS-polyacrylamide gels and native gels (data not
shown)). Several other protein substrates, such as -casein,
-casein, insulin, and insulin -chain, were not hydrolyzed by
Hsp31 in a test tube assay, in several types of experimental
conditions (0.01–0.05% SDS- or Triton-containing buffers, par-
tial thermal unfolding (15), presence of 1 mM ATP and 5 mM
magnesium chloride), suggesting that Hsp31 does not function
as a broad specificity protease (data not shown). We could not
detect any significant autolytic activity of Hsp31 in a test tube
assay as described under “Experimental Procedures.” Hsp31
underwent proteolysis in an in-gel assay consisting of a poly-
acrylamide gel loaded with purified Hsp31, run in SDS, subse-
quently transferred for 90 min into phosphate buffer contain-
ing 2% Triton X-100, and incubated overnight in the same
buffer without detergent and finally colored with Coomassie
Blue (data not shown). However, such proteolysis was also
observed with the C185A mutant (deficient in the nucleophilic
cysteine, see below), suggesting that it results from a contam-
inating in-gel proteolytic activity.
Aminopeptidase Activity of Hsp31—We studied the cleavage
specificity of Hsp31 for aminoacyl-amc fluorescent substrates.
Hsp31 hydrolyzed five out of the 18 aminoacyl-amc substrates
tested. Alanine, arginine, lysine, and histidine substrates were
hydrolyzed with a decreasing efficiency in that order (Fig. 1A).
This suggests that Hsp31 is a broad specificity aminopeptidase
2 T. Baba, T. Ara, Y. Okumura, M. Hasegawa, Y. Takai, M. Baba,
K. A. Datsenko, T. Oshima, M. Tomita, B. L. Wanner, and H. Mori,
submitted for publication.
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cleaving after alanine and basic amino acids. Kinetic charac-
terization revealed that Hsp31 displays higher kcat/Km values
for Ala (kcat  1.1 min
1; Km  120 M; kcat/Km  0.01
min1M1), Lys (kcat  0.43 min
1; Km  55 M; kcat/Km 
0.008 min1M1), and Arg (kcat  0.51 min
1; Km  95 M;
kcat/Km  0.005 min
1M1) in that order. The apparent kcat
values of Hsp31 are of the same order of magnitude as those of
several aminopeptidases, such as PepD (24) or as the endopep-
tidase activity of PepN (16, 17), but are much lower than the
aminopeptidase activity of PepN, the major aminopeptidase of
E. coli (16, 17).
To exclude the possibility that small amounts of contaminat-
ing PepN were responsible for these aminopeptidase activities,
we purified Hsp31 further on a DEAE-Sephacel column. The
alanine and arginine aminopeptidase activities were detected
in the same fractions as the Hsp31 protein peak, suggesting
that Hsp31 is responsible for these activities (Fig. 1B). Similar
results were obtained when purified Hsp31 was analyzed on a
hydroxylapatite column (data not shown).
When compared with A-amc (100% activity), AAA-amc was
hydrolyzed with less efficiency (5%), and neither acetyl-A-amc
(0.2 per 100 of the activity observed with A-amc) nor benzy-
loxycarbonyl-AAA-amc (0.2 per 100 of the activity observed
with A-amc) was cleaved by Hsp31, suggesting that Hsp31 has
no endopeptidase activity (Fig. 1C). succinyl-LLVY-amc, t-bu-
tyloxycarbonyl-LAR-amc, and Ac-YVAD-amc were neither
cleaved by Hsp31 (data not shown; Ref. 3). All the experiments
described above were also carried out in the presence of 5 mM
ATP and 2 mM MgCl2 and gave similar results (data not
shown).
Inhibitors of Hsp31 Aminopeptidase Activity and Mutational
Test of the Nucleophilic Activity of Cys185—We tested the amin-
opeptidase activity of Hsp31 in the presence of several inhibi-
tors known to affect cysteine proteases (iodoacetamide and
dithiothreitol), serine proteases (phenylmethylmethylsulfonyl
fluoride), and metalloproteases (EDTA and 1,10-phenanthro-
line) (Fig. 2). Iodoacetamide completely blocks the ability of
Hsp31 to degrade Ala-amc. Hsp31 is also severely inhibited by
10 mM dithiothreitol (80% inhibition). In contrast, the serine
protease inhibitor PMSF had little effect on Hsp31. More im-
portantly, the aminopeptidase activity of Hsp31 was com-
pletely abolished in a C185A mutant, suggesting that, in ac-
cordance with crystallographic data, Cys185 is the active
nucleophile of Hsp31. Metalloprotease inhibitors strongly in-
hibit Hsp31: 5 mM EDTA and 5 mM 1,10-phenanthroline pro-
voke a 95% inhibition of the Hsp31 aminopeptidase. This sug-
gests that the putative His85, His122, and Glu90 metal-binding
site of Hsp31 revealed by crystallographic studies (6) is impor-
tant for its aminopeptidase activity. Hsp31 inhibitors are dif-
ferent from PepN inhibitors. PepN is strongly inhibited by
PMSF but not by EDTA nor by iodoacetamide (16–17).
Effect of Temperature, pH, Divalent Cations, and ATP on the
Hsp31 Aminopeptidase—Since Hsp31 is a heat shock protein
and displays chaperone activity, we suspected that its amin-
opeptidase activity might be revealed at high temperatures, in
a manner reminiscent of that of the temperature-dependent
switch from chaperone to protease of DegP/HtrA (this switch
FIG. 1. Hsp31 is a broad specificity aminopeptidase. A, Hsp31
was assayed for aminopeptidase activity toward aminoacyl-amc sub-
strates. Pure Hsp31 (1 g) was incubated at 37 °C with different ami-
noacyl-amc or peptidyl-amc derivatives (0.5 mM) as described under
“Experimental Procedures.” The free amc released after substrate hy-
drolysis by Hsp31 was measured in a spectrofluorimeter. The legend on
the right represents the single letter code for the amino acids that are
present at the amino terminus of the peptide bond hydrolyzed. “1000
arbitrary units” represents a specific activity of 2120 nmol/h/mg Hsp31.
B, chromatography of purified Hsp31 on a DEAE-Sephacel column.
Purified Hsp31 (20 g) was applied to a DEAE-Sephacel column equil-
ibrated in 50 mM Tris, pH 8 (1 ml, Pharmacia Corp.) and eluted with a
sodium chloride gradient (0–0.5 M) in the same buffer. Fractions were
collected and analyzed for protein by the Braford method (squares), for
Ala-amc hydrolysis (circles), and for Arg-amc hydrolysis (triangles)
spectrofluorimetrically, as described in legend to A. C, Hsp31 was
assayed for its ability to hydrolyze A-amc, AAA-amc, AcA-amc, and
benzyloxycarbonyl (Z)-AAA-amc in the same conditions as described
for A.
FIG. 2. Inhibitors of Hsp31 aminopeptidase activity and muta-
tional test of the nucleophilic activity of Cys185. Various amounts
of each inhibitor, dithiothreitol (DTT), iiodoacetamide (IAA), PMSF,
EDTA, and 1,10-phenanthroline were incubated with Hsp31 (1 g) and
Ala-amc (0.5 mM). The activity was dosed spectrofluorimetrically fol-
lowing a 3-h incubation at 37 °C. An activity of 100 represents 2060
nmol/h/mg of protein. The last column represents the aminopeptidase
activity toward Ala-amc of 1 g of the C185A Hsp31 mutant tested in
the same conditions. o-Phen, o-phenanthroline.
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occurs at temperatures ranging between 30 and 40 °C) (18).
The dependence of the Hsp31 aminopeptidase activity on tem-
perature within the range of 20–45 °C displays a classical
curve with a Q10 of around 2, suggesting that, unlike DegtP/
HtrA, there is not an exceptional activation of Hsp31 by heat
shock temperatures (Fig. 3A).
The aminopeptidase activity of Hsp31 was optimal around
pH 8 and was greatly decreased below pH 6 and above pH 9
(Fig. 3B).
In crystallographic studies of Hsp31, a zinc ion was observed,
coordinated by His85, Glu90, and His122. Consistent with this
observation, Hsp31 is almost completely inhibited by 5 mM
o-phenanthroline, which has a particularly high affinity for
zinc (Fig. 2). Furthermore, in the presence of 2 mM o-phenan-
throline, the alanine aminopeptidase activity of Hsp31 was
inhibited to 8% of the control and it could be reactivated up to
48% by 50 M Zn2 (and up to 14% by 50 M Mn2), but not by
magnesium, calcium, iron, or cobalt divalent cations at 10–100
M (Fig. 3C), suggesting that Zn2 is the metal cofactor of
Hsp31.
Since ATP interacts with Hsp31 and inhibits some of its
chaperone properties (4), we tested the aminopeptidase activi-
ties of Hsp31 as described in the above sections, in the presence
of 5 mM ATP and 2 mM MgCl2, and found that ATP was without
any effect (data not shown).
Peptide Accumulated during Growth of an Hsp31-deficient
Mutant—To test the hypothesis that the absence of Hsp31
leads to peptide accumulation during bacterial growth, the
following experiment was performed. The Hsp31-deficient and
parental strains were grown for several generations at 37 °C in
the presence of [3H]leucine. The cells were harvested and
washed, and the material that was soluble in 1 M acetic acid
FIG. 4. Analysis of accumulated peptides in an Hsp31-deficient
strain and a control strain. HPLC C18 reverse phase chromatogra-
phy of peptides from the Hsp31-deficient strain JW1950 and from its
parental strain BW25113. Cells were labeled during growth at 37 °C
with [3H]leucine, washed by centrifugation, and extracted with 1 M
acetic acid as described under “Experimental Procedures.” The acetic
extracts of cultures were first chromatographed on a TSK 2000 HPLC
column, and the low molecular mass peak (100–3000 Da) was lyophi-
lized and chromatographed on a Vydac C18 reverse phase HPLC col-
umn equilibrated in water containing 0.1% trifluoroacetic acid. The
column was eluted with a linear gradient of 0–100% acetonitrile con-
taining 0.1% trifluoroacetic acid at a rate of 0.3 ml/min, and fractions of
0.3 ml were collected. A, the chromatograms represent the absorbance
at 215 nm of extracts from the wild-type strain (thin line) and the
hcha-deficient strain (thick line). 100 arbitrary units represents an
absorbance of 0.084 at 215 nm. B, fractions from the hcha-deficient
strain extract, whose chromatogram is shown in Fig. 6A (thick line),
were tested for fluorescamine reactivity before (open circles) and after
(filled circles) hydrolysis in base and for [3H]leucine radioactivity (tri-
angles). 10 arbitrary units represents 11 nmol of N-terminal (fluores-
camine detection) or 120 cpm ([3H]leucine radioactivity). The straight
line starting at tube 10 represents the 0–100% acetonitrile gradient.
FIG. 3. Temperature and pH dependence of the aminopepti-
dase activity of Hsp31. A, the activity of Hsp31 (1 g) was assayed
between 30 °C and 50 °C with 0.5 mM Ala-amc as described under
“Experimental Procedures.” An activity of 100 represents 490 nmol/
h/mg of protein. B, the activity of Hsp31 (1 g) was assayed at 37 °C
between pH 6 and 9 with 0.5 mM Ala-amc, 5 mM MgCl2, 1 mM dithio-
threitol, 1% dimethyl sulfoxide in a total volume of 100 l. The pH
values were made with 50 mM phosphate or Tris buffers and were
normalized to Tris buffer. An activity of 100 represents 2220 nmol/h/mg
of protein. C, reactivation of Hsp31 by Zn2. Hsp31 (1 g) was incu-
bated in 100 l of 50 mM Tris, pH 8.0, in the presence of 2 mM
o-phenanthroline and 50 M zinc, manganese, magnesium, calcium,
iron, or cobalt divalent cation (90 min at 25 °C), and its activity was
assayed at 37 °C with 0.5 mM Ala-amc as described under “Experimen-
tal Procedures.” 100% represents the Hsp31 activity without added
phenanthroline or cation, and the Hsp31 activity in the presence of 2
mM o-phenanthroline alone was 8% of the control.
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was extracted (14). The acetic acid-soluble fractions from the
two cultures were subjected to gel filtration on a HPLC TSK
2000 SW gel permeation column. Both cultures displayed a
similar peak of radioactivity with a molecular mass of around
100–3000 Da (not shown). Peak fractions were pooled, concen-
trated by lyophilization, and subjected to reverse phase chro-
matography on a C18 HPLC column equilibrated with water
containing 0.1% trifluoroacetic acid and eluted with a linear
0–100% acetonitrile gradient in 0.1% trifluoroacetic acid. As
shown in Fig. 4A, the elution profile of peptides from the
Hsp31-deficient strain is different from that of the wild-type
strain. The Hsp31-deficient strain accumulates a higher quan-
tity of peptides eluting between 50 and 80% acetonitrile (8–12-
mers, see below) and fewer peptides eluting between 0 and 30%
acetonitrile (3–5-mers, see below). The quality of peptides ac-
cumulating in the Hsp31-deficient strain was studied by the
following procedure: fractions eluting from the C18 column
were assayed for [3H]leucine radioactivity, fluorescamine reac-
tivity (NH2 terminus determination), and fluorescamine reac-
tivity after peptide hydrolysis in base, as described in (14) (Fig.
4B). The results of this experiment indicate that (i) the radio-
active material applied on the C18 column is heterogeneous,
and (ii) all fractions contain fluorescamine positive material,
(iii) the fluorescamine detection is severalfold increased by
prior hydrolysis in base. These data indicate that the material
present in the peptidase-deficient strain is a heterogeneous
mixture of peptides. The ratio of fluorescamine values before
and after hydrolysis in base gives an estimation of the average
length of peptides in each peak. Peptide length ranges from
3–5-mers (in fractions eluting between 0–30% acetonitrile) to
8–12-mers (in fractions eluting between 50 and 80% acetoni-
trile). Similar results were obtained for peptides of the control
strain (not shown), except that, as shown in Fig. 7A, there was
a higher amount of 3–5-mer peptides and a lower amount of
8–12-mer peptides.
To analyze further the action of Hsp31 on these natural
peptides, the acetic acid-soluble fraction (the 500–3000-Da
peak from the TSK 2000 SW gel filtration HPLC column) from
the Hsp31-deficient strain was subjected to gel filtration on a
Bio-Gel P-2 permeation column, before and after incubation
with purified Hsp31. As shown in Fig. 5, the [3H]leucine radio-
activity of peptides from the Hsp31-deficient strain elutes as a
broad peak, corresponding to 200–1500-Da molecular mass
peptides (2–12-mers; the size of these peptides is in accordance
with that obtained above by fluorescamine detection experi-
ments). After incubation for 2 h in the presence of purified
Hsp31, there is a decrease in the amount of high molecular
weight peptides and a concomittant increase in the amount of
low molecular weight peptides (Fig. 5), suggesting that Hsp31
exerts a peptidase effect on these natural peptides. Longer
incubation times did not significantly increase peptide hydrol-
ysis, which implies that the combined action of several pepti-
dases is required in vivo for their complete hydrolysis (data not
shown).
One can postulate, from the results presented in this section,
that Hsp31 is involved in the processing of 8–12-mer peptides
(approximatively the size of the peptides produced by ATP-de-
pendent endopeptidases) both in vitro and in vivo.
The growth phenotype of the Hsp31-deficient strain was
similar to that of its parental strain, either in minimal or rich
medium (data not shown). Furthermore, there was no increase
in the lag time (before resuming exponential growth) of the
mutant after shift from nutrient broth to minimal glucose
medium. These negative results are not surprising, since only
multiple peptidase mutants (pepN, pepA, pepB, pepD) display a
slow growth phenotype or an increased lag time after nutri-
tional downshift (the increased lag time results from a defi-
ciency in the degradation of intracellular proteins to amino
acids required for the synthesis of new proteins) (14).
Proteins Interacting with Hsp31—We used affinity purifica-
tion and mass spectrometry to characterize the proteins that
specifically interact with Hsp31. A chimera protein of Hsp31
fused to a chitin-binding domain was bound on a chitin affinity
column as described under “Experimental Procedures.” An E.
coli crude extract was loaded onto this Hsp31 affinity column in
the presence of 0.5 M NaCl, and the column was extensively
washed with 0.5 M NaCl. After the NaCl wash, the remaining
proteins were eluted with SDS. They were then separated by
denaturing gel electrophoresis; individual protein bands were
digested by trypsin, analyzed by MALDI-TOF mass spectrom-
etry, and identified by data base algorithms. Hsp31 specifically
retained four proteins (Table I), which were characterized as
the ATPase component ClpA of the ClpAP protease (19), the
chaperone GroEL (2), translation elongation factor EF-Tu (20–
22), and tryptophanase (an enzyme that degrades tryptophan
to indole and pyruvate) (23). None of these proteins was re-
tained on a control chitin affinity column or on an YhbO affinity
column (YhbO is another E. coli peptidase under study in our
laboratory; data not shown). The interaction observed between
Hsp31 and ClpA is in accordance with its function as an amin-
opeptidase involved in the downstream processing of peptides
produced by endopeptidases such as ClpAP or Lon. The inter-
action between Hsp31 and GroEL is consistent with the chap-
erone and peptidase function of Hsp31, since the GroEL chap-
erone has also been implicated in proteolysis (2). The
interaction between Hsp31 and EF-Tu can be accounted for by
the recently discovered chaperone functions of EF-Tu (20–22).
We cannot provide a straightforward explanation, however, for
the interaction of Hsp31 with tryptophanase, although it is
noteworthy that tryptophanase is involved in E. coli protection
against alkali stress (see “Discussion” and Ref. 23).
DISCUSSION
We show in this study that Hsp31 does not display any
significant proteolytic activity but displays an aminopeptidase
activity that is specific against peptide substrates with alanine
or basic amino acids at N terminus and is inhibited by iodoac-
etamide, EDTA, and 1,10-phenanthroline. Furthermore, an
Hsp31-deficient strain accumulates higher quantities of 8–12-
mer peptides than its parental strain, and Hsp31 can process
these peptides to smaller peptides, which suggests that it is
involved in the processing of 8–12-mer peptides both in vitro
and in vivo.
FIG. 5. Bio-Gel P-2 chromatography of peptides before and
after hydrolysis by purified Hsp31. Gel permeation chromatogra-
phy on a Bio-Gel P-2 column (2 ml bed volume) of the low molecular
mass peak (100–3000 Da) of the TSK 2000 HPLC column loaded with
the hcha-deficient strain extract before (open circles) and after (closed
circles) incubation for 2 h in the presence of 2 g of purified Hsp31 as
described under “Experimental Procedures.” Arrows 1–3 indicate the
elution volume of Dextran Yellow (20,000 Da), vitamin B12 (1350 Da),
and leucine (131 Da), respectively.
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The proteolytic activity of Hsp31 is negligible with several
protein substrates frequently used for protease studies, such as
gelatin, - or -casein, insulin, and insulin -chain. Further-
more, no proteolytic activity could be detected in the presence
of low amounts of detergents, upon partial unfolding of the
protein substrate by temperature increase, or by other types of
treatments that have the potential to stimulate the activity of
various proteases. This is consistent with previous results,
which concluded that Hsp31 does not display any proteolytic
activity (3, 4) (however, a very weak proteolytic activity of
Hsp31 toward bovine serum albumin has been reported in (7)).
It is also consistent with the restricted accessibility of the
Cys-His-Asp catalytic triad of Hsp31, through a small pocket
14 Å long with an entrance of about 4 Å in diameter (5–7) that
appears to confine the substrate spectrum of Hsp31 to peptides
rather than protein substrates.
Hsp31 functions as a broad specificity aminopeptidase,
which cleaves alanine and basic amino acid substrates better
than others. The specific aminopeptidase activity of Hsp31
(2120 nmol/h/mg of protein), which is of the same order of
magnitude as PepD (1260 nmol/h/mg of protein (24)), is consid-
erably lower than that of PepN (2  107 nmol/h/mg of protein),
the major E. coli aminopeptidase (16, 17). We have shown that
the aminopeptidase activities assigned to Hsp31 are not con-
taminated by PepN by extensive purification of Hsp31 and by a
different inhibitor sensitivity of Hsp31 and PepN; in contrast
with Hsp31, PepN is not inhibited by EDTA or iodoacetamide
but is, however, inhibited by PMSF (16–17). Hsp31 does not
display any significant endopeptidase activity, since it does not
cleave Ac-alanine-amc and other peptides blocked at their N
terminus nor does it possess any carboxypeptidase activity, as
reported previously (3). The hydrolysis of Ala-amc and Gly-amc
has been reported by Lee et al. (7) but not that of Arg-amc,
Lys-amc, and His-amc.
The aminopeptidase activity of Hsp31 is inhibited by the
cysteine protease inhibitor iodoacetamide and is completely
abolished in the C185A mutant. This is in accordance with
crystallographic results suggesting that Cys185 is the active
nucleophile of Hsp31 (5). Metalloprotease inhibitors (EDTA
and 1,10-phenanthroline) also inhibit Hsp31. This suggests
that the putative His85, His122, and Glu90 metal-binding site
revealed by crystallographic studies is important for Hsp31
activity (6). Zn2 is the only divalent metal ion that is able to
reactivate Hsp31 after inhibition by o-phenanthroline, suggest-
ing that it is the biologically relevant cofactor of Hsp31, as
suggested in crystallographic studies (6).
Hsp31 shows a classical kinetic dependence on temperature,
in contrast with DegP/HtrA which displays a temperature-de-
pendent switch from chaperone to protease between 30 and
40 °C, with an impressive increase in proteolytic activity in
that temperature range (18).
It seems likely that Hsp31 plays an important physiological
function in peptide degradation, since an Hsp31-deficient
strain accumulates higher amounts of 8–12-mer peptides than
its parental strain, and since purified Hsp31 can process these
peptides to smaller peptides in vitro (this study). Several pep-
tidase-deficient mutants of Salmonella typhimurium (a pepN
pepA pepB pepD mutant (14), a pepP mutant, and a pepQ
mutant (25)) also accumulate small peptides during exponen-
tial growth in minimal medium. It is generally assumed that
5–15-mer peptides are produced by ATP-dependent proteases
involved in the intracellular regulated protein breakdown (Cl-
pAP, ClpXP, Lon, HslUV, and FtsH in E. coli (26) and the
proteasome in eucaryotes (10)), and both the processing of
8–12-mer peptides by Hsp31 and its interaction with ClpA
strengthens the hypothesis of its involvement in the processing
of peptides resulting from intracellular proteolysis. The accu-
mulation of 8–12-mer peptides in the Hsp31-deficient strain,
despite the presence of more efficient peptidases such as PepN,
suggests that Hsp31 can degrade several classes of peptides
that are not easily cleaved by other peptidases or that it helps
in the degradation of peptides by other peptidases.
Reverse purification of a crude E. coli extract on an Hsp31
affinity column led to the detection of four proteins, ClpA,
GroEL, EF-Tu, and tryptophanase, which specifically interact
with Hsp31. None of these proteins interacted with two control
columns containing either the chitin-binding domain used for
Hsp31 purification or the E. coli peptidase YhbO. The interac-
tion between Hsp31 and the GroEL chaperone suggests that
Hsp31, which might function as a holding chaperone (4), could
deliver unfolded proteins to the GroEL/ES chaperone machine
for refolding. Recent work reported a possible cooperation be-
tween Hsp31 and the DnaK chaperone machine (27), and it is
possible that a cooperation also occurs with the GroEL chap-
erone machine. The interaction between Hsp31 and elongation
factor EF-Tu can be explained in light of the recently discov-
ered function of elongation factors as chaperones and nascent
chain-binding proteins (20–22); it has been suggested that
eEF-1A (the eukaryotic homolog of EF-Tu) functions as a key
component of the protein quality control mechanism (22), and a
cooperation between Hsp31 and EF-Tu could be envisioned for
such a function. The interaction between Hsp31 and ClpA
strengthens the hypothesis that Hsp31 is involved in the in-
tracellular protein/peptide degradation pathway. ClpA/ClpP is
one of the ATP-dependent proteases exerting a function in
intracellular protein degradation, which produce peptides of
5–15 amino acids that are cleaved further by peptidases such
as PepN, PepB, PepD, PepE, PepQ, PepT, AmpA, and Hsp31
(25). The Hsp31-ClpA interaction suggests that ATP-depend-
ent proteases and peptidases could form a degradosome com-
plex, allowing channeling of peptides from proteases to pepti-
dases. It is possible that Hsp31 interacts with tryptophanase,
given that tryptophanase takes part in the alkali stress re-
sponse (23). The latter is involved in degrading not only tryp-
tophan but also serine and cysteine for catabolism. It produces
pyruvic acid, which can be further degraded to acetic and
TABLE I
Proteins interacting with Hsp31
An E. coli crude extract was loaded on a Hsp31-affinity column in the presence of 0.5 M NaCl. The column was washed with 0.5 M NaCl, and
proteins bound to Hsp31 were eluted with 1% SDS and separated by denaturing gel electrophoresis. The individual bands were digested by trypsin,
analyzed by MALDI-TOF mass spectrometry, and identified by data base algorithms.
Name Function Molecular mass
kDa
ClpA Chaperone component of the ClpAP ATP-dependent protease 84
GroEL Chaperone component of the GroEL/GroES chaperone machine 57
EF-Tu Translational elongation factor 45
Recently characterized chaperone
TnaA Tryptophanase 53
Alkali stress protein
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formic acids, both of which neutralize excess alkali. The Hsp31
chaperone might specifically protect tryptophanase against de-
naturation under these stress conditions.
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